EQL Pharma AB publ announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced sales was SEK 25.805 million compared to SEK 18.817 million a year ago. Operating loss was SEK 5.881 million compared to operating Income of SEK 319,000 a year ago. Net loss was SEK 6.233 million compared to net income of SEK 162,000 a year ago.